Wellorithm vs bmiMD: 50-state access vs multi-month pricing
Quick verdict: For national telehealth access choose Wellorithm; for transparent tirzepatide subscription pricing choose bmiMD. This comparison of Wellorithm vs bmiMD highlights the main differences so you can decide fast.
How Wellorithm vs bmiMD differ at a glance
The two providers both offer compounded GLP-1 treatment options, but they diverge meaningfully on clinician coverage, medication options, and pricing structure. Below we compare the most distinctive supported differences: state coverage, medications offered, pricing models and billing options, clinician access and shipping, and regulatory notes.
1. State coverage and clinician network
Wellorithm: Licensed clinicians in all 50 states is stated as a primary feature, presented as a solution for patients in states with limited GLP-1 telehealth options. bmiMD: Available state coverage is not detailed in the captured evidence, so no direct claim about 50-state clinician coverage is supplied for bmiMD.
2. Medications offered
Wellorithm offers both compounded semaglutide and compounded tirzepatide according to the source. bmiMD focuses on compounded tirzepatide (GLP-1/GIP) in the captured evidence. If access to semaglutide compounds matters, Wellorithm explicitly lists both agents; bmiMD evidence emphasizes tirzepatide.
3. Pricing model and billing options
Wellorithm: Advertising examples include “Only $147” and multiple “starting at” price points for different compounded products, and the site states you receive a personalized quote after completing an intake quiz. The source notes that Wellorithm does not publish full pricing until intake is complete.
bmiMD: Provides explicit tirzepatide subscription tiers with monthly equivalents: $179 month-to-month; $159 per month for a three-month plan; $149 per month for a six-month plan; and $139 per month for a 12-month plan. The captured evidence states the lowest price requires a 12-month commitment and that total prepaid charge should be confirmed.
4. Clinician access, refills, and shipping
Wellorithm: Uses fully virtual consultations with medication shipped to your home after an online assessment and ongoing virtual check-ins. bmiMD: Emphasizes online refills and delivery, free subscription shipping, and 24/7 clinician access for enrolled patients. Both use state-licensed pharmacy compounding for their medications per the captured descriptions.
5. Regulatory and quality notes
Both sources include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Wellorithm explicitly states compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. bmiMD includes the same regulatory note in its captured evidence.
| Criteria | Wellorithm | bmiMD |
|---|---|---|
| State clinician coverage | Licensed clinicians in all 50 states | State availability not detailed in captured evidence |
| Medications offered | Compounded semaglutide and tirzepatide | Compounded tirzepatide (GLP-1/GIP) |
| Pricing model | Personalized quote after intake; examples show starting at $147 | Subscription tiers: $179, $159, $149, $139 per month |
| Shipping and refills | Medication shipped to home after virtual consult; free shipping examples | Free subscription shipping; online refills and delivery |
| Clinician access | Virtual consultations with ongoing check-ins | 24/7 clinician access for enrolled patients |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Comparing real user-facing commitments and tradeoffs
Wellorithm promotes broad clinician coverage and both compound options, but it does not publish full pricing until an intake quiz is completed, which means you get a personalized quote. bmiMD lists clear monthly pricing tiers for tirzepatide with multi-month discounts but notes the lowest monthly equivalent requires a longer commitment and that total prepaid charges should be confirmed. Both platforms state the same regulatory limitation about compounded medications.
Bottom line and who should pick which
Wellorithm vs bmiMD boils down to coverage and pricing transparency. Wellorithm is best if you need licensed clinicians in all 50 states and want access to both compounded semaglutide and tirzepatide, recognizing pricing is provided after intake. bmiMD is best if you want clear tirzepatide subscription tiers up front and are willing to consider longer commitments to reach the lowest monthly rate. Both providers use compounded medications that are not FDA-approved.
Choose Wellorithm if…
- You need licensed clinicians in all 50 states or access to both compounded semaglutide and tirzepatide.
- You accept receiving a personalized pricing quote after completing the intake quiz.
Choose bmiMD if…
- You want explicit tirzepatide subscription pricing with multi-month pricing tiers from $179 down to $139 per month and free subscription shipping.
- You are prepared to confirm total prepaid charges and consider longer commitments to lower the monthly equivalent.
Final note: Wellorithm vs bmiMD both sell compounded medications and include the regulatory reminder that compounded products are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. If other details are important to you, the captured evidence for each provider should be reviewed directly.